Expression of growth factors in the conjunctiva from patients with active trachoma

Eye

Volumn 20, Issue 3, 2006, Pages 362-369

  Abu El Asrar, A M ^a,c   Al Kharashi, S A ^a   Missotten, L ^b   Geboes, K ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Angiogenesis; Conjunctiva; Fibrosis; Growth factors; Trachoma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; ENDOGLIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TENASCIN; VASCULOTROPIN;

ADOLESCENT; ANGIOGENESIS; ARTICLE; BLINDNESS; CELL ACTIVITY; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONJUNCTIVA; CONJUNCTIVAL BIOPSY; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROSIS; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MONOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TISSUE DISTRIBUTION; TISSUE GROWTH; TRACHOMA; VASCULAR ENDOTHELIUM;

EID: 33646231992     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701884     Document Type: Article

References (39)

1. Mabey DCW, Solomon AW, Foster A. Trachoma. Lancet 2003; 362: 223-229.
2. Abu El-Asrar AM, Van den Oord JJ, Geboes K, Missotten L, Emarah NM, Desmet V. Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol 1989; 73: 276-282.
3. Abu El-Asrar AM, Geboes K, Tabbara KF, Al-Kharashi SA, Missotten L, Desmet V. Immunopathogenesis of conjunctival scarring in trachoma. Eye 1998; 12: 453-460.
4. Abu El-Asrar AM, Geboes K, Al-Kharashi SA, Al-Mosallam AA, Missotten L, Paemen L et al. Expression of gelatinase B in trachmatous conjunctivitis. Br J Ophthalmol 2000; 84: 85-91.
5. Esposito I, Bergmann F, Penzel R, di Mola FF, Shrikhande S, Büchler MW et al. Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: An immunohistochemical and molecular analysis. Virchows Arch 2004; 444: 119-126.
6. Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy? Matrix Biol 2002; 21: 473-482.
7. Gupta S, Clarkson MR, Duggan J, Brady H. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 2000; 58: 1389-1399.
8. Okada-Ban M, Thiery JP, Jouanneau J. Fibroblast growth factor-2. Int J Biochem Cell Biol 2000; 32: 263-267.
9. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
10. Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003; 17: 984-992.
11. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 2000; 218: 235-259.
12. Kovacs EJ, Di Pietro LA. Fibrogenic cytokines and connective tissue production. FASEB J 1994; 8: 854-861.
13. Tsuneyama K, Kouda W, Nakanuma Y. Portal and parenchymal alterations of the liver in idiopathic portal hypertension: A histological and immunochemical study. Pathol Res Pract 2002; 198: 597-603.
14. Hughes SE, Crossman D, Hall PA. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 1993; 27: 1214-1219.
15. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauck M et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997; 95: 831-839.
16. Allen JT, Knight RA, Bloor CA, Spiteri MA. Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1999; 21: 693-700.
17. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995; 105: 280-284.
18. Rachfal AW, Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003; 26: 1-9.
19. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998; 30: 909-922.
20. Razzaque MS, Forster CS, Ahmed R. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003; 44: 1998-2003.
21. Van Setten G, Aspiotis M, Blalock TD, Grotendorst G, Schultz G. Connective tissue growth factor in pterygium: Simultaneous presence with vascular endothelial growth factor-possible contributing factor to conjunctival scarring. Graefe's Arch Clin Exp Ophthalmol 2003; 241: 135-139.
22. Abu El-Asrar AM, Geboes K, Al-Kharashi SA, Tabbara KF, Missotten L. Collagen content and types in trachomatous conjunctivitis. Eye 1998; 12: 735-739.
23. Abu El-Asrar AM, Geboes K, Al-Kharashi SA, Al-Mosallam AA, Tabbara KF, Al-Rajhi AA et al. An immunohistochemical study of collagens in trachoma and vernal keratoconjunctivitis. Eye 1998; 12: 1001-1006.
24. Ruegg CR, Chiquet-Ehrismann R, Alkan SS. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci USA 1989; 86: 7437-7441.
25. Canfield AE, Schor AM. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J Cell Sci 1995; 108: 797-809.
26. Khan KMF, Falcone DJ. Role of laminin induction of macrophage urokinase-type plasminogen activator and 92-KDa metalloproteinase expression. J Biol Chem 1997; 272: 8270-8275.
27. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404-411.
28. Wang JF, Olson ME, Ball DK, Brigstock DR, Hart DA. Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression. Wound Rep Reg 2003; 11: 220-229.
29. Gore-Hyer E, Shegogue D, Markiewicz M, Lo S, Hazen-Martin D, Greene EL et al. TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 2002; 283: F707-F716.
30. Jadhav U, Chigurupati S, Lakka SS, Mohanam S. Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 2004; 25: 1407-1414.
31. Johnson C, Sung HJ, Lessner SM, Fini ME, Galis ZS. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: Potential role in capillary branching. Circ Res 2004; 94: 262-268.
32. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991; 5: 2145-2154.
33. Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 2002; 5: 153-165.
34. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T et al. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002; 23: 769-776.
35. Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B et al. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 279: L371-L378.
36. Jin J, Guan M, Sima J, Gao G, Zhang M, Liu Z et al. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea 2003; 22: 473-477.
37. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995; 270: 31189-31195.
38. Torsney E, Charton R, Parums D, Collis M, Arthur HM. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res 2002; 51: 464-470.
39. Dales JP, Garcia S, Bonnier P, Duffaud F, Andrac-Meyer L, Ramuz O et al. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlation between immunohistochemical analysis and long-term follow-up in a series of 929 patients. Am J Clin Pathol 2003; 119: 374-380.